HOMA-IR 6. 4 at 29 — metformin needed?

Your fasting glucose is normal, but your HbA1c (5.7%), elevated fasting insulin, and HOMA-IR indicate significant insulin resistance. However, HOMA-IR alone is not an indication to start metformin. Current ADA and AACE guidance recommends that intensive lifestyle modification with 7–10% weight loss is the first-line treatment, as it is the most effective intervention for reversing insulin resistance and reducing diabetes risk. Given your BMI of 31 kg/m², hypertension, and fatty liver, you are also an appropriate candidate to discuss GLP-1 receptor agonist therapy (e.g., semaglutide or tirzepatide) for obesity management, as these agents produce greater weight loss and improve insulin resistance, NAFLD, and cardiometabolic risk. Metformin can be considered if prediabetes progresses (especially HbA1c ≥5.7% with additional high-risk features) or if lifestyle measures are insufficient, but it is not mandatory solely because HOMA-IR is elevated. Repeat HbA1c, liver enzymes, and metabolic parameters after 3–6 months of lifestyle intervention.

Next steps: * Target ≥7–10% weight loss. * Follow a calorie-restricted Mediterranean/high-protein diet and perform ≥150 min/week of aerobic activity plus resistance training. * Correct vitamin D deficiency. * Screen for dyslipidemia and assess NAFLD severity (consider FibroScan/FIB-4 if indicated). * Reassess HbA1c, fasting glucose, and liver function in 3–6 months.

Pl follow endocrinologist advise. Diet control, exercise, and life style modification.

Need a few more details please consult for further evaluation and treatment

Kindly follow your endocrinologist advise